Celltrion Archives | Be Korea-savvy
Celltrion’s Biosimilars Overtaking Originals in U.S., Europe

Celltrion’s Biosimilars Overtaking Originals in U.S., Europe

SEOUL, Apr. 27 (Korea Bizwire) — South Korea’s pharmaceutical giant Celltrion has become a strong competitor to European and U.S. drugs with its biosimilars, indicated by changes in sales, industry officials said Friday. Multinational drugmaker Roche logged a 44 percent fall in sales of Mabthera, an antibody used to treat rheumatoid arthritis, lymphoma and some [...]

Celltrion’s Truxima Drug to Sell in Colombia

Celltrion’s Truxima Drug to Sell in Colombia

SEOUL, Feb. 21 (Korea Bizwire) — South Korean biopharmaceutical firm Celltrion Inc.’s biosimilar drug Truxima will reach the Colombian market, the company’s affiliate said Wednesday. Global drug firm Mundi Pharma Inc. won exclusive rights to distribute and market the copy of Roche’s blockbuster medicine, also known as MabThera, in the South American country, Celltrion Healthcare [...]

Drugmaker Celltrion Surpasses Hyundai Motor in Market Value

Drugmaker Celltrion Surpasses Hyundai Motor in Market Value

SEOUL, Jan. 8 (Korea Bizwire) – Drugmaker Celltrion Inc.’s stock has made significant gains in recent days, surpassing Hyundai Motor Co. in terms of market value, data showed Monday. Celltrion shares jumped 55.12 percent over the past 7 trading sessions to 302,500 won (US$283.29) on Monday closing, pushing the company’s capitalization to a record 37.1 trillion won. Hyundai Motor’s market capitalization stood at 33.2 trillion won as of Monday closing. Celltrion’s [...]